Related Experiment Video
Updated: Oct 3, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Alterations of CD163 expression in the complications of diabetes: A systematic review
Elisha Siwan1, Stephen M Twigg2, Danqing Min2
1Greg Brown Diabetes and Endocrinology Research Laboratory, Sydney Medical School (Central), Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Australia.
Aims:
Diabetes mellitus is a state of chronic low-grade inflammation. Scavenger receptor CD163, expressed on monocyte/macrophage cells with anti-inflammatory functions, has been observed in diabetes complications. This review aimed to systematically survey human studies published until 31st January 2022 for CD163 expression, in particular diabetes complications and additionally to investigate whether CD163 may be implicated as a biomarker of, and mediator in, the progression of diabetes complications.
Methods:
A systematic literature search undertaken in Scopus, Embase and Medline established 79 papers of relevance. Data extraction and assessment followed the PRISMA workflow.
Results:
Based on specific criteria, 11 studies totalling 821 participants were included in this review. CD163 was quantified in various forms including soluble, cell surface, and mRNA measures. This review found that soluble CD163 was upregulated in diabetes complications in various local body fluids and systemically in plasma or serum and therefore implicated in the progression of those complications. CD163+ cells and mRNA were variably expressed across diabetes complications.
Conclusions:
CD163 was altered in series of diabetes complications and the circulating sCD163 has potential utility as an inflammation biomarker. The variable expression of CD163 on cell surfaces and its mRNA across different diabetes complications warrants further systematic investigation.
Insights
Soluble CD163 levels increase with diabetes complications, suggesting its role as an inflammation biomarker. Further research is needed to understand CD163
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Diabetes mellitus is characterized by chronic inflammation.
- Scavenger receptor CD163, an anti-inflammatory marker on macrophages, is linked to diabetes complications.
Purpose of the Study:
- To systematically review human studies on CD163 expression in diabetes complications.
- To investigate CD163's potential as a biomarker and mediator in diabetes progression.
Main Methods:
- Systematic literature search of Scopus, Embase, and Medline databases.
- Inclusion of 11 studies with 821 participants following PRISMA guidelines.
- Quantification of CD163 via soluble, cell surface, and mRNA measures.
Main Results:
- Soluble CD163 (sCD163) was upregulated in plasma/serum and local body fluids of patients with diabetes complications.
- sCD163 is implicated in the progression of diabetes complications.
- CD163+ cells and mRNA expression showed variable patterns across complications.
Conclusions:
- Altered CD163 expression is observed in various diabetes complications.
- Circulating sCD163 shows potential as an inflammation biomarker for diabetes.
- Further investigation into variable CD163 cell surface and mRNA expression is warranted.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Psychoneuroimmunology: Diabetes and Cancer

